ID GROA_HUMAN Reviewed; 107 AA. AC P09341; Q9UCR7; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1989, sequence version 1. DT 02-SEP-2026, entry version 229. DE RecName: Full=Growth-regulated alpha protein; DE AltName: Full=C-X-C motif chemokine 1; DE AltName: Full=GRO-alpha(1-73); DE AltName: Full=Melanoma growth stimulatory activity; DE Short=MGSA; DE AltName: Full=Neutrophil-activating protein 3; DE Short=NAP-3; DE Contains: DE RecName: Full=GRO-alpha(4-73); DE Contains: DE RecName: Full=GRO-alpha(5-73); DE Contains: DE RecName: Full=GRO-alpha(6-73); DE Flags: Precursor; GN Name=CXCL1; Synonyms=GRO, GRO1, GROA, MGSA, SCYB1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2890161; DOI=10.1073/pnas.84.20.7188; RA Anisowicz A., Bardwell L., Sager R.; RT "Constitutive overexpression of a growth-regulated gene in transformed RT Chinese hamster and human cells."; RL Proc. Natl. Acad. Sci. U.S.A. 84:7188-7192(1987). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2970963; DOI=10.1002/j.1460-2075.1988.tb03042.x; RA Richmond A., Balentien E., Thomas H.G., Flaggs G., Barton D.E., Spiess J., RA Bordoni R., Francke U., Derynck R.; RT "Molecular characterization and chromosomal mapping of melanoma growth RT stimulatory activity, a growth factor structurally related to beta- RT thromboglobulin."; RL EMBO J. 7:2025-2033(1988). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Blood; RX PubMed=2129556; DOI=10.1093/nar/18.21.6453; RA Baker N.E., Kucera G., Richmond A.; RT "Nucleotide sequence of the human melanoma growth stimulatory activity RT (MGSA) gene."; RL Nucleic Acids Res. 18:6453-6453(1990). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Ovary; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PROTEIN SEQUENCE OF 35-107, IDENTIFICATION OF GRO-ALPHA(4-73); RP GRO-ALPHA(5-73) AND GRO-ALPHA(6-73), PROTEOLYTIC PROCESSING OF N-TERMINAL, RP AND FUNCTION. RC TISSUE=Peripheral blood monocyte; RX PubMed=10095777; DOI=10.1046/j.1432-1327.1999.00166.x; RA Wuyts A., Govaerts C., Struyf S., Lenaerts J.-P., Put W., Conings R., RA Proost P., Van Damme J.; RT "Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor RT cells and leukocytes reveals NH2-terminal heterogeneity. Functional RT comparison of different natural isoforms."; RL Eur. J. Biochem. 260:421-429(1999). RN [7] RP PROTEIN SEQUENCE OF 35-65. RX PubMed=2182761; DOI=10.1084/jem.171.4.1091; RA Schroeder J.-M., Persoon N.L.M., Christophers E.; RT "Lipopolysaccharide-stimulated human monocytes secrete, apart from RT neutrophil-activating peptide 1/interleukin 8, a second neutrophil- RT activating protein. NH2-terminal amino acid sequence identity with melanoma RT growth stimulatory activity."; RL J. Exp. Med. 171:1091-1100(1990). RN [8] RP PROTEIN SEQUENCE OF 35-57. RX PubMed=2655583; DOI=10.1042/bj2590585; RA Golds E.E., Mason P., Nyirkos P.; RT "Inflammatory cytokines induce synthesis and secretion of gro protein and a RT neutrophil chemotactic factor but not beta 2-microglobulin in human RT synovial cells and fibroblasts."; RL Biochem. J. 259:585-588(1989). RN [9] RP PROTEIN SEQUENCE OF 35-51. RC TISSUE=Skin; RX PubMed=1755384; DOI=10.1007/978-1-4684-6009-4_12; RA Schroeder J.-M.; RT "Biochemical and biological characterization of NAP-1/IL-8-related RT cytokines in lesional psoriatic scale."; RL Adv. Exp. Med. Biol. 305:97-107(1991). RN [10] RP PROTEIN SEQUENCE OF 35-49. RX PubMed=15340161; DOI=10.1110/ps.04682504; RA Zhang Z., Henzel W.J.; RT "Signal peptide prediction based on analysis of experimentally verified RT cleavage sites."; RL Protein Sci. 13:2819-2824(2004). RN [11] RP POSSIBLE FUNCTION. RX PubMed=2670560; DOI=10.1002/j.1460-2075.1989.tb03569.x; RA Wen D., Rowland A., Derynck R.; RT "Expression and secretion of gro/MGSA by stimulated human endothelial RT cells."; RL EMBO J. 8:1761-1766(1989). RN [12] RP STRUCTURE BY NMR. RX PubMed=8397104; DOI=10.1016/0014-5793(93)80893-y; RA Fairbrother W.J., Reilly D., Colby T., Horuk R.; RT "1H assignment and secondary structure determination of human melanoma RT growth stimulating activity (MGSA) by NMR spectroscopy."; RL FEBS Lett. 330:302-306(1993). RN [13] RP STRUCTURE BY NMR. RX PubMed=8089846; DOI=10.1006/jmbi.1994.1577; RA Fairbrother W.J., Reilly D., Colby T., Hesselgesser J., Horuk R.; RT "The solution structure of melanoma growth stimulating activity."; RL J. Mol. Biol. 242:252-270(1994). RN [14] RP STRUCTURE BY NMR. RX PubMed=7806518; DOI=10.1016/s0021-9258(20)30077-6; RA Kim K.S., Clark-Lewis I., Sykes B.D.; RT "Solution structure of GRO/melanoma growth stimulatory activity determined RT by 1H NMR spectroscopy."; RL J. Biol. Chem. 269:32909-32915(1994). CC -!- FUNCTION: Has chemotactic activity for neutrophils. May play a role in CC inflammation and exerts its effects on endothelial cells in an CC autocrine fashion. In vitro, the processed forms GRO-alpha(4-73), GRO- CC alpha(5-73) and GRO-alpha(6-73) show a 30-fold higher chemotactic CC activity. {ECO:0000269|PubMed:10095777}. CC -!- INTERACTION: CC P09341; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-2806484, EBI-16439278; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- PTM: N-terminal processed forms GRO-alpha(4-73), GRO-alpha(5-73) and CC GRO-alpha(6-73) are produced by proteolytic cleavage after secretion CC from peripheral blood monocytes. {ECO:0000269|PubMed:10095777}. CC -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC) family. CC {ECO:0000305}. CC -!- WEB RESOURCE: Name=Wikipedia; Note=CXCL1 entry; CC URL="https://en.wikipedia.org/wiki/CXCL1"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J03561; AAA35933.1; -; mRNA. DR EMBL; X12510; CAA31027.1; -; mRNA. DR EMBL; X54489; CAA38361.1; -; Genomic_DNA. DR EMBL; BT006880; AAP35526.1; -; mRNA. DR EMBL; BC011976; AAH11976.1; -; mRNA. DR CCDS; CCDS47074.1; -. DR PIR; S13669; A28414. DR RefSeq; NP_001502.1; NM_001511.4. DR PDB; 1MGS; NMR; -; A/B=35-107. DR PDB; 1MSG; NMR; -; A/B=35-106. DR PDB; 1MSH; NMR; -; A/B=35-106. DR PDB; 1ROD; NMR; -; A/B=40-62, A/B=89-107. DR PDB; 8K4O; EM; 3.01 A; F=35-97. DR PDB; 8XWA; EM; 3.48 A; D/E=35-107. DR PDB; 8XWV; EM; 3.07 A; D/E=35-102. DR PDB; 9EJC; EM; 2.98 A; F=35-107. DR AlphaFoldDB; P09341; -. DR EMDB; EMD-36888; -. DR EMDB; EMD-38732; -. DR EMDB; EMD-38743; -. DR EMDB; EMD-43718; -. DR EMDB; EMD-48100; -. DR SMR; P09341; -. DR BioGRID; 109176; 24. DR DIP; DIP-5896N; -. DR FunCoup; P09341; 1029. DR IntAct; P09341; 21. DR MINT; P09341; -. DR NDEx; IQUERY-CP-CXCL1; 16 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000379110; -. DR PhosphoSitePlus; P09341; -. DR SwissPalm; P09341; -. DR BioMuta; CXCL1; -. DR DMDM; 121622; -. DR jPOST; P09341; -. DR MassIVE; P09341; -. DR PaxDb; 9606-ENSP00000379110; -. DR PeptideAtlas; P09341; -. DR ProteomicsDB; 52214; -. DR ABCD; P09341; 3 sequenced antibodies. DR Antibodypedia; 6268; 785 antibodies from 42 providers. DR DNASU; 2919; -. DR Ensembl; ENST00000395761.4; ENSP00000379110.3; ENSG00000163739.6. DR GeneID; 2919; -. DR KEGG; hsa:2919; -. DR MANE-Select; ENST00000395761.4; ENSP00000379110.3; NM_001511.4; NP_001502.1. DR UCSC; uc003hhh.4; human. DR AGR; HGNC:4602; -. DR ClinPGx; PA35050; -. DR CTD; 2919; -. DR DisGeNET; 2919; -. DR GeneCards; CXCL1; -. DR HGNC; HGNC:4602; CXCL1. DR HPA; ENSG00000163739; Tissue enhanced (cervix, lymphoid tissue). DR MIM; 155730; gene. DR OpenTargets; ENSG00000163739; -. DR VEuPathDB; HostDB:ENSG00000163739; -. DR eggNOG; ENOG502S7MM; Eukaryota. DR GeneTree; ENSGT00940000164504; -. DR HOGENOM; CLU_143902_1_1_1; -. DR InParanoid; P09341; -. DR OMA; NTELRCR; -. DR OrthoDB; 8872899at2759; -. DR PAN-GO; P09341; 0 GO annotations based on evolutionary models. DR PhylomeDB; P09341; -. DR PathwayCommons; P09341; -. DR Reactome; R-HSA-380108; Chemokine receptors bind chemokines. DR Reactome; R-HSA-418594; G alpha (i) signalling events. DR Reactome; R-HSA-6783783; Interleukin-10 signaling. DR Reactome; R-HSA-6798695; Neutrophil degranulation. DR SignaLink; P09341; -. DR SIGNOR; P09341; -. DR Agora; ENSG00000163739; -. DR BioGRID-ORCS; 2919; 15 hits in 1093 CRISPR screens. DR ChiTaRS; CXCL1; human. DR EvolutionaryTrace; P09341; -. DR GeneWiki; CXCL1; -. DR GenomeRNAi; 2919; -. DR Pharos; P09341; Tbio. DR PRO; PR:P09341; -. DR Proteomes; UP000005640; Chromosome 4. DR RNAct; P09341; protein. DR Bgee; ENSG00000163739; Expressed in olfactory segment of nasal mucosa and 157 other cell types or tissues. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0035580; C:specific granule lumen; TAS:Reactome. DR GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome. DR GO; GO:0008009; F:chemokine activity; TAS:ProtInc. DR GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc. DR GO; GO:0008083; F:growth factor activity; TAS:GO_Central. DR GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc. DR GO; GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc. DR GO; GO:0006935; P:chemotaxis; TAS:ProtInc. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc. DR GO; GO:0006955; P:immune response; IEA:InterPro. DR GO; GO:0006954; P:inflammatory response; TAS:ProtInc. DR GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc. DR GO; GO:0008285; P:negative regulation of cell population proliferation; TAS:ProtInc. DR GO; GO:0007399; P:nervous system development; TAS:ProtInc. DR GO; GO:0007165; P:signal transduction; TAS:ProtInc. DR CDD; cd00273; Chemokine_CXC; 1. DR FunFam; 2.40.50.40:FF:000004; C-X-C motif chemokine; 1. DR Gene3D; 2.40.50.40; -; 1. DR InterPro; IPR039809; Chemokine_b/g/d. DR InterPro; IPR001089; Chemokine_CXC. DR InterPro; IPR018048; Chemokine_CXC_CS. DR InterPro; IPR001811; Chemokine_IL8-like_dom. DR InterPro; IPR033899; CXC_Chemokine_domain. DR InterPro; IPR036048; Interleukin_8-like_sf. DR PANTHER; PTHR12015:SF192; GROWTH-REGULATED ALPHA PROTEIN; 1. DR PANTHER; PTHR12015; SMALL INDUCIBLE CYTOKINE A; 1. DR Pfam; PF00048; IL8; 1. DR PRINTS; PR00436; INTERLEUKIN8. DR PRINTS; PR00437; SMALLCYTKCXC. DR SMART; SM00199; SCY; 1. DR SUPFAM; SSF54117; Interleukin 8-like chemokines; 1. DR PROSITE; PS00471; SMALL_CYTOKINES_CXC; 1. DR PDBsum; 1MGS; -. DR PDBsum; 1MSG; -. DR PDBsum; 1MSH; -. DR PDBsum; 1ROD; -. DR PDBsum; 8K4O; -. DR PDBsum; 8XWA; -. DR PDBsum; 8XWV; -. DR PDBsum; 9EJC; -. PE 1: Evidence at protein level; KW 3D-structure; Cytokine; Direct protein sequencing; Disulfide bond; KW Growth factor; Inflammatory response; Proteomics identification; KW Reference proteome; Secreted; Signal. FT SIGNAL 1..34 FT /evidence="ECO:0000269|PubMed:10095777, FT ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:1755384, FT ECO:0000269|PubMed:2182761, ECO:0000269|PubMed:2655583" FT CHAIN 35..107 FT /note="Growth-regulated alpha protein" FT /id="PRO_0000005049" FT CHAIN 38..107 FT /note="GRO-alpha(4-73)" FT /id="PRO_0000005050" FT CHAIN 39..107 FT /note="GRO-alpha(5-73)" FT /id="PRO_0000005051" FT CHAIN 40..107 FT /note="GRO-alpha(6-73)" FT /id="PRO_0000005052" FT DISULFID 43..69 FT DISULFID 45..85 FT HELIX 36..38 FT /evidence="ECO:0007829|PDB:9EJC" FT STRAND 41..43 FT /evidence="ECO:0007829|PDB:1MSG" FT STRAND 44..47 FT /evidence="ECO:0007829|PDB:8K4O" FT STRAND 49..51 FT /evidence="ECO:0007829|PDB:1MSG" FT TURN 54..56 FT /evidence="ECO:0007829|PDB:9EJC" FT STRAND 58..62 FT /evidence="ECO:0007829|PDB:8K4O" FT STRAND 66..68 FT /evidence="ECO:0007829|PDB:8K4O" FT STRAND 69..71 FT /evidence="ECO:0007829|PDB:8XWV" FT STRAND 74..77 FT /evidence="ECO:0007829|PDB:9EJC" FT TURN 79..81 FT /evidence="ECO:0007829|PDB:1ROD" FT STRAND 83..86 FT /evidence="ECO:0007829|PDB:9EJC" FT STRAND 88..90 FT /evidence="ECO:0007829|PDB:9EJC" FT HELIX 93..105 FT /evidence="ECO:0007829|PDB:9EJC" SQ SEQUENCE 107 AA; 11301 MW; 17048A6B4D765CA2 CRC64; MARAALSAAP SNPRLLRVAL LLLLLVAAGR RAAGASVATE LRCQCLQTLQ GIHPKNIQSV NVKSPGPHCA QTEVIATLKN GRKACLNPAS PIVKKIIEKM LNSDKSN //